Headache Impact Test (HIT-6)
Posted on July 31 2023,
HIT-6 is a reliable and valid tool for discriminating headache impact across episodic and chronic migraine. It was designed to provide a global measure of adverse headache impact and was developed to use in screening and monitoring patients with headaches in both clinical practice and clinical research.
The four headache impact severity categories are little or no impact (49 or less), some impact (50–55), substantial impact (56–59), and severe impact (60–78).
Reference: Yang M, Rendas-Baum R, Varon SF, Kosinski M. Validation of the Headache Impact Test (HIT-6TM) across episodic and chronic migraine. Cephalalgia. 2011;31(3):357-367. doi:10.1177/0333102410379890.
Mon, Nov 17, 25
Migraine Research - During the week of my absence.
Migraine Research - During the week of my absence. The Association Between Insomnia and Migraine Disability and Quality of Life This study examined how insomnia severity relates to migraine disability...
Read MoreSat, Nov 01, 25
Anti-CGRP Monoclonal Antibody Migraine Treatment: Super-Responders and Absolute Responders and When to Expect Results
Anti-CGRP monoclonal antibodies achieved 70% super-response and 23% complete migraine freedom in a one-year study. Most dramatic improvements occurred after 6 months of treatment. For patients with chronic or high-frequency...
Read MoreAll Non-Invasive Neuromodulation Devices for Migraine Treatment
Wondering if migraine devices actually work? This guide breaks down the latest evidence on non-invasive neuromodulation devices like Cefaly, Nerivio, and gammaCore. Learn which devices have solid research backing them,...
Read More
